Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Novo Nordisk recently published favorable results from the FLOW renal outcomes trial, which found that Ozempic (semaglutide) 1.0 mg lowered the risk of kidney disease progression and kidney and ...
Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...
The approval comes after the Biden administration selected three of Novo Nordisk's drugs with the active ingredient semaglutide for the second cycle of Medicare drug price negotiations.
(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the ... chemically known as semaglutide, to become the first GLP-1 treatment option for people with type 2 diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results